NYMC > News and Events > NYMC in the News

Ketamine Nasal Spray Shows Promise Against Depression, Suicide

April 16, 2018

Matthew Lorber, M.D., M.P.A."This study only had 68 people enrolled, which is a limitation, so there really needs to be larger-scale studies before being able to confidently recommend ketamine as a first-line choice," said Dr. Matthew Lorber, a psychiatrist at Lenox Hill Hospital in New York City.

NYMC faculty: Matthew Lorber, M.D., M.P.A., clinical assistant professor of psychiatry and behavioral sciences

Source: Health